PadPro Model 2516
by Padpro, LLC
510(k) K020203
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK020203 | Date8 May 2002 | StatusActive |
Recalls
-
- Terminated Z-0458-2015
- Terminated Z-0457-2015
Philips Healthcare made changes to the design of the connection between multifunction electrodes and their HeartStart FR3 and HeartStart FRx AEDs. The failure to connect may result in a delay of therapy, which could result in patient death or serious injury.
-
- Terminated Z-0756-2007
- Terminated Z-0757-2007
Firm was notified of three incidents over the past 15 months in which customers opened the pouch & found an incorrect connector. This error makes the product unusable. The Zoll and Medtronic connectors are not interchangeable and are unique to their specific device.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MKJ
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.5310
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The PadPro Model 2516 is an Automated External Defibrillator (Non-Wearable), designed to deliver electrical shocks to restore normal heart rhythm during cardiac arrest. It incorporates external electrodes for defibrillation, external pacing, and cardiac monitoring, enabling emergency responders to manage sudden cardiac events outside of a clinical setting.
This device is supplied as a non-sterile, single-use or reusable system (as indicated by the regulatory submission) and is classified as Class III under FDA regulations. It is intended for use in pre-hospital and public access defibrillation programs, with no specific MRI safety restrictions noted. The Model 2516 is authorized under FDA 510(k) clearance (K020203) and adheres to regulatory requirements outlined in 21 CFR 870.5310. Storage and handling follow standard protocols for defibrillator equipment.
Other devices from Padpro, LLC
Questions
AI-generated answers, 18 Sep 2026
Can the PadPro Model 2516 be reused after a single use, or is it strictly single-use only?
The PadPro Model 2516 is designed as a single-use or reusable system, as indicated in the regulatory submission. Whether it is reused depends on facility protocols and maintenance practices, but the device itself is not inherently restricted to single-use. Reuse must follow proper cleaning, disinfection, and inspection procedures to ensure safety and functionality, especially since it is classified as a Class III medical device under FDA regulations.
What types of environments or settings is the PadPro Model 2516 intended for, and how does its design support those uses?
The PadPro Model 2516 is specifically designed for pre-hospital and public access defibrillation programs, meaning it is meant for emergency responders and lay rescuers outside of clinical settings (e.g., ambulances, public spaces, or worksites). Its design includes external electrodes for defibrillation, pacing, and cardiac monitoring, allowing non-medical personnel to manage sudden cardiac events effectively. The device does not have MRI safety restrictions, making it suitable for general emergency use.
How should the PadPro Model 2516 be stored, and are there any special handling requirements for this device?
Storage and handling of the PadPro Model 2516 follow standard protocols for defibrillator equipment, as noted in the regulatory data. Since it is non-sterile, it does not require sterile storage conditions, but it should be kept in a clean, dry environment to prevent damage or contamination. If reused, it must undergo proper cleaning and maintenance to ensure reliability. Always refer to the manufacturer’s instructions for specific storage guidelines.
What regulatory pathway was followed for the FDA clearance of the PadPro Model 2516, and what does that mean for its use?
The PadPro Model 2516 was cleared via an FDA 510(k) pathway (K020203), classified as Substantially Equivalent (SESE) under the Cardiovascular (CV) Advisory Committee. This means the device was determined to be at least as safe and effective as a legally marketed predicate device, allowing it to enter the market without requiring a full Premarket Approval (PMA). The clearance adheres to 21 CFR 870.5310, ensuring compliance with FDA standards for Automated External Defibrillators (Non-Wearable).